Glaxo Wellcome
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- ZANTAC solution for injection 25 mg/ml
- A04 - Antieméticos y antinauseosos
- ZOFRAN film-coated tablet 4 mg
- ZOFRAN film-coated tablet 8 mg
- ZOFRAN solution for injection 4 mg/2 ml
- ZOFRAN solution for injection 8 mg/4 ml
- ZOFRAN suppository 16 mg
- ZOFRAN syrup 0.8 mg/ml
- ZOFRAN ZYDIS oral lyophilisate 8 mg
- C08 - Bloqueantes del canal de calcio
- LACIPIL film-coated tablet 4 mg
- LACIPIL film-coated tablet 6 mg
- D07 - Preparados dermatológicos con corticosteroides
- BETNOVATE C cream
- BETNOVATE C cream 0.1%+3%
- BETNOVATE C ointment
- BETNOVATE C ointment 0.1%+3%
- BETNOVATE CAPILAR cutaneous solution 0.1%
- BETNOVATE cream 0.1%
- BETNOVATE N cream
- BETNOVATE N cream 0.1%+3 500 IU/g
- BETNOVATE N ointment
- BETNOVATE N ointment 0.1%+3 500 IU/g
- BETNOVATE ointment 0.1%
- CUTIVATE cream 0.05%
- CUTIVATE ointment 0.005%
- DERMOVATE cream 0.05%
- DERMOVATE cutaneous solution 0.05%
- DERMOVATE ointment 0.05%
- EMOVATE cream 0.05%
- EMOVATE ointment 0.05%
- G04 - Urológicos
- AVODART capsule, soft 0.5 mg
- COMBODART prolonged-release capsule, hard 0.4 mg+0.5 mg
- J01 - Antibacterianos para uso sistémico
- CEFORTAM powder and solvent for solution for injection 1 g+3 ml
- CEFORTAM powder and solvent for solution for injection 500 mg+1.5 ml
- CEFORTAM powder for solution for injection 2 g
- CUROXIME powder and solvent for solution for injection 750 mg
- ZOREF coated tablet 250 mg
- ZOREF coated tablet 500 mg
- ZOREF granules for oral suspension 125 mg/5 ml
- ZOREF granules for oral suspension 250 mg/5 ml
- J05 - Antivirales de uso sistémico
- RELENZA inhalation powder, pre-dispensed 5 mg/dose
- ZEFFIX coated tablet 100 mg
- ZEFFIX oral solution 5 mg/ml
- N02 - Analgésicos
- IMIGRAN nasal spray, solution 10 mg/0.1 ml
- IMIGRAN nasal spray, solution 20 mg/0.1 ml
- IMIGRAN solution for injection 6 mg/0.5 ml
- IMIGRANRADIS dispersible tablet 50 mg
- NARAMIG film-coated tablet 2.5 mg
- N06 - Psicoanalépticos
- ZYBAN prolonged-release tablet 150 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- FLIXOTAIDE DISKUS inhalation powder 100 µg/dose
- FLIXOTAIDE DISKUS inhalation powder 250 µg/dose
- FLIXOTAIDE DISKUS inhalation powder 50 µg/dose
- FLIXOTAIDE DISKUS inhalation powder 500 µg/dose
- FLIXOTAIDE NEBULES nebuliser suspension 0.5 mg/2 ml
- FLIXOTAIDE pressurised inhalation, suspension 125 µg/dose
- FLIXOTAIDE pressurised inhalation, suspension 250 µg/dose
- FLIXOTAIDE pressurised inhalation, suspension 50 µg/dose
- SERETAIDE DISKUS inhalation powder, pre-dispensed 50 µg+100 µg
- SERETAIDE DISKUS inhalation powder, pre-dispensed 50 µg+250 µg
- SERETAIDE DISKUS inhalation powder, pre-dispensed 50 µg+250 µg
- SERETAIDE pressurised inhalation, suspension 25 µg+125 µg
- SERETAIDE pressurised inhalation, suspension 25 µg+250 µg
- SERETAIDE pressurised inhalation, suspension 25 µg+50 µg
- SEREVENT DISKUS inhalation powder 50 µg/dose
- SEREVENT pressurised inhalation, suspension 25 µg/dose
- VENTILAN INALADOR pressurised inhalation, suspension 100 µg/dose
- VENTILAN nebuliser solution 5 mg/ml
- VENTILAN ROTACAPS inhalation powder, hard capsule 200 µg
- VENTILAN ROTACAPS inhalation powder, hard capsule 400 µg
- VENTILAN solution for infusion 5 mg/5 ml
- VENTILAN solution for injection 0.5 mg/1 ml
- VENTILAN syrup 2 mg/5 ml
- VENTILAN tablet 4 mg
- R05 - Preparados para la tos y el resfriado
- PROPAVENTE syrup 10 mg/ml+0.2 mg/ml